IDEX Biometrics (IDEX) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
29 May, 2026Executive summary
Achieved record order backlog of NOK 23.4 million at Q1 2026 end, driven by a USD 1.75 million ID Centric order, with all deliveries set for 2026.
Signed seven new pilots, including Telenor Cyberdefence and StormGeo; two are live, others launching through summer, with significant pipeline growth post-Mythos announcement.
FIDO2 certification in February 2026 removed a key deployment blocker, accelerating enterprise and public-sector interest.
Channel partner network expanded by eight, broadening reach in Norway, Europe, and APAC.
Senior commercial hires strengthen go-to-market execution.
Financial highlights
Q1 2026 revenue was NOK 1.8 million, up from NOK 0.7 million in Q4 2025 and NOK 1.1 million in Q1 2025.
Gross margin reached 58%, supported by favorable sensor mix and commercial sensor orders.
Operating expenses (OpEx, excl. SBC) were NOK 19.1 million, down 44% year-over-year and flat sequentially.
Adjusted EBITDA loss narrowed to NOK -18.1 million, halved year-over-year.
Cash position post-private placement and debt repayment is NOK 49.6 million, with no financial debt.
Outlook and guidance
Strong growth expected in 2026 as pilots convert to full-scale orders and new partnerships are formed.
Revenue recognition will align with shipment completion and pilot scaling; H2 2026 expected to see step-change in order intake and revenue.
Operating costs will rise in Q2 due to commercial ramp and sales/marketing hires, but incremental revenue is expected to contribute at high margin.
Latest events from IDEX Biometrics
- Certified biometric products launched, costs cut, but liquidity and sales targets remain challenges.IDEX
Q4 20253 Mar 2026 - Q2 revenue was $0.4M, margin 40%, costs down, but liquidity and growth risks remain.IDEX
Q2 20241 Feb 2026 - Q3 saw cost cuts, capital raised, and major biometric card approvals amid market risks.IDEX
Q3 202418 Jan 2026 - Q3 2025 saw a 60% OPEX drop, new biometric card launches, and ongoing liquidity risk.IDEX
Q3 202513 Nov 2025 - Biometric access cards drive growth, aiming for breakeven in Q4 2025.IDEX
Company Presentation3 Sep 2025 - Q1 2025 saw a $4.1M net loss, liquidity strain, and urgent need for new funding.IDEX
Q1 20253 Sep 2025 - Cost reductions and new funding support ongoing operations amid continued losses and product launches.IDEX
Q2 202527 Aug 2025 - No Q4 revenue, net loss, and liquidity risk, but certifications and launches support future growth.IDEX
Q4 20245 Jun 2025